Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction

被引:61
作者
Cardoso, Rosa [1 ]
Love, Robert [1 ]
Nilsson, Carol L. [1 ]
Bergqvist, Simon [2 ]
Nowlin, Dawn [2 ]
Yan, Jiangli [1 ]
Liu, Kevin K. -C. [1 ]
Zhu, Jing [3 ]
Chen, Ping [1 ]
Deng, Ya-Li [1 ]
Dyson, H. Jane [3 ]
Greig, Michael J. [1 ]
Brooun, Alexei [1 ]
机构
[1] Pfizer Inc, Oncol Chem, Worldwide Res & Dev, San Diego, CA 92121 USA
[2] Pfizer Inc, Oncol Res Unit, Worldwide Res & Dev, San Diego, CA 92121 USA
[3] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
关键词
protein-protein interaction (PPI); crystal structure; covalent inhibitor; NMR spectroscopy; mass spectrometry; AlphaScreen; surface plasmon resonance (SPR); isothermal titration calorimetry (ITC); HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; LIGAND-BINDING; CDDO-ME; KINASE; HIF-1; HETERODIMERIZATION; DISCOVERY; RECEPTOR;
D O I
10.1002/pro.2172
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heterodimer HIF-1a (hypoxia inducible factor)/HIF-beta (also known as ARNT-aryl hydrocarbon nuclear translocator) is a key mediator of cellular response to hypoxia. The interaction between these monomer units can be modified by the action of small molecules in the binding interface between their C-terminal heterodimerization (PasB) domains. Taking advantage of the presence of several cysteine residues located in the allosteric cavity of HIF-1a PasB domain, we applied a cysteine-based reactomics hotspot identification strategy to locate regions of HIF-1a PasB domain critical for its interaction with ARNT. COMPOUND 5 was identified using a mass spectrometry-based primary screening strategy and was shown to react specifically with Cys255 of the HIF-1a PasB domain. Biophysical characterization of the interaction between PasB domains of HIF-1a and ARNT revealed that covalent binding of COMPOUND 5 to Cys255 reduced binding affinity between HIF-1a and ARNT PasB domains approximately 10-fold. Detailed NMR structural analysis of HIF-1a-PasB-COMPOUND 5 conjugate showed significant local conformation changes in the HIF-1a associated with key residues involved in the HIF-1a/ARNT PasB domain interaction as revealed by the crystal structure of the HIF-1a/ARNT PasB heterodimer. Our screening strategy could be applied to other targets to identify pockets surrounding reactive cysteines suitable for development of small molecule modulators of protein function.
引用
收藏
页码:1885 / 1896
页数:12
相关论文
共 44 条
[1]   Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179 [J].
Ahmad, Rehan ;
Raina, Deepak ;
Meyer, Colin ;
Kharbanda, Surender ;
Kufe, Donald .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (47) :35764-35769
[2]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[3]   Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development [J].
Buettner, Ralf ;
Corzano, Renzo ;
Rashid, Rumana ;
Lin, Jianping ;
Senthil, Maheswari ;
Hedvat, Michael ;
Schroeder, Anne ;
Mao, Allen ;
Herrmann, Andreas ;
Yim, John ;
Li, Hongzhi ;
Yuan, Yate-Ching ;
Yakushijin, Kenichi ;
Yakushijin, Fumiko ;
Vaidehi, Nagarajan ;
Moore, Roger ;
Gugiu, Gabriel ;
Lee, Terry D. ;
Yip, Richard ;
Chen, Yuan ;
Jove, Richard ;
Horne, David ;
Williams, John C. .
ACS CHEMICAL BIOLOGY, 2011, 6 (05) :432-443
[4]   Structural basis of ARNT PAS-B dimerization: Use of a common beta-sheet interface for hetero- and homodimerization [J].
Card, PB ;
Erbel, PJA ;
Gardner, KH .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 353 (03) :664-677
[5]   Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2 [J].
Choi, H. J. ;
Song, B-J ;
Gong, Y-D ;
Gwak, W. J. ;
Soh, Y. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (01) :114-125
[6]   Structural bioinformatics-based design of selective, irreversible kinase inhibitors [J].
Cohen, MS ;
Zhang, C ;
Shokat, KM ;
Taunton, J .
SCIENCE, 2005, 308 (5726) :1318-1321
[7]   HIGH-RESOLUTION EPITOPE MAPPING OF HGH-RECEPTOR INTERACTIONS BY ALANINE-SCANNING MUTAGENESIS [J].
CUNNINGHAM, BC ;
WELLS, JA .
SCIENCE, 1989, 244 (4908) :1081-1085
[8]   Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible factor [J].
Erbel, PJA ;
Card, PB ;
Karakuzu, O ;
Bruick, RK ;
Gardner, KH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15504-15509
[9]   Tethering: Fragment-based drug discovery [J].
Erlanson, DA ;
Wells, JA ;
Braisted, AC .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2004, 33 :199-223
[10]   Fragment-based approach to drug lead discovery - Overview and advances in various techniques [J].
Fattori, Daniela ;
Squarcia, Antonella ;
Bartoli, Sandra .
DRUGS IN R&D, 2008, 9 (04) :217-227